Ceros Capital Markets

GT Metabolic Solutions is a company focused on developing innovative medical technologies aimed at improving bariatric, metabolic, and digestive surgeries. The company has created a minimally-invasive gastrointestinal device system that utilizes a magnetic connection within the gastrointestinal tract. This approach allows medical professionals to perform procedures with reduced invasiveness compared to traditional surgical methods, potentially enhancing patient outcomes and recovery times. By prioritizing less invasive techniques, GT Metabolic Solutions is positioned to make significant advancements in the field of gastroenterology.

DermaSensor, Inc. is a Miami-based company that specializes in developing innovative technology for skin cancer evaluation. Founded in 2009, the company has created a handheld device that employs artificial intelligence, machine learning, and elastic scattering spectroscopy to assess skin lesions for potential cancer. This device enables both physicians and consumers to perform skin checks in various settings, including clinics and at home. By providing an efficient and affordable solution for early skin cancer detection, DermaSensor aims to improve access to vital healthcare services and reduce the costs associated with skin cancer diagnosis. The technology not only identifies cancerous cells but also sends alerts when such cells are detected, facilitating timely intervention.

Pristine Surgical LLC is a Manchester, New Hampshire-based company that specializes in developing and marketing a pioneering single-use digital imaging platform for surgical and diagnostic procedures. Founded in 2011, the company offers high-definition digital arthroscopes and laparoscopes, which are delivered in 100% sterile kits, ensuring safety and efficiency in over 23 million procedures annually. By integrating advanced LED lighting, artificial intelligence, and cloud-based software, Pristine Surgical aims to enhance the surgical experience for patients and healthcare providers alike. Its innovative platform reduces costs, minimizes the risk of cross-contamination associated with reprocessing, and streamlines communication through HIPAA-compliant video and text features. This technology not only drives efficiency throughout the surgical episode but also improves overall satisfaction for surgeons and medical centers.

Pathology Watch Inc. is a company that specializes in providing remote specimen interpretation services through its digital pathology solution, primarily for hospitals, laboratories, and dermatology centers. Founded in 2017 and headquartered in Salt Lake City, Utah, the company collaborates with dermatopathologists and subspecialized pathologists to interpret digital slides, pathology reports, and biopsy slides. By digitizing the pathology workflow, Pathology Watch enhances the quality of patient care while reducing costs and creating new revenue opportunities for clinical practices. Additionally, the company offers telepathology services tailored for large clinics and hospitals, ensuring efficient and effective pathology services.